Pharmaceutical Technology1 小时
Risk adjusted net present value: What is the current valuation of Ono Pharmaceutical’s ...
Vimseltinib is a small molecule commercialized by Ono Pharmaceutical, with a leading Pre-Registration program in Tenosynovial Giant Cell Tumor.
Pharmaceutical Technology1 小时
Risk adjusted net present value: What is the current valuation of Philogen’s Fibromun?
Fibromun is a fusion protein commercialized by Philogen, with a leading Phase III program in Soft Tissue Sarcoma.